Will be published November 20, the lastest.
We are a Swedish medical technology company listed on NGM Nordic SME.
Chordate has spent more than 10 years developing the Kinetic Oscillation Stimulation, K.O.S, a technique for treating rhinitis and migraine. We have a patent on K.O.S in the EU and the United States, as well as many other countries.
We have answered frequently asked questions in our FAQ. If you want to know more, please get in touch.
This website uses cookies to give you the best and most relevant user experience. Using this website means you consent to the use of cookies. Find out more about cookies on our website.